wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q27005966-51F1CDFF-FD82-45F4-B959-569B5925525B
Q27005966-51F1CDFF-FD82-45F4-B959-569B5925525B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27005966-51F1CDFF-FD82-45F4-B959-569B5925525B
European perspective on multiple myeloma treatment strategies in 2014
P2860
Q27005966-51F1CDFF-FD82-45F4-B959-569B5925525B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27005966-51F1CDFF-FD82-45F4-B959-569B5925525B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ffc8fb8c53e6b11422b3beb98239a755fdc1d85e
P2860
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients.